Literature DB >> 17097453

Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?

Aysel Celikbas1, Onder Ergonul, Sabahat Aksaray, Nilden Tuygun, Harika Esener, Gonul Tanir, Sebnem Eren, Nurcan Baykam, Engin Guvener, Basak Dokuzoguz.   

Abstract

BACKGROUND: To investigate the immune status of health care workers (HCWs) against measles, rubella, mumps, and varicella zoster (MMRV) in Turkey and to define an appropriate vaccination program among HCWs.
METHODS: Voluntary HCWs from a children's hospital and a general hospital were included in the study between March and May 2005. The specific IgG antibodies against MMRV viruses were screened by ELISA.
RESULTS: Three hundred sixty-three HCWs participated in the study; 186 (51%) were physicians, 118 (33%) were nurses, 36 (10%) were housekeeping staff, and 23 (6%) were medical technicians. The proportion of HCWs who had antibodies against measles was 98.6%; rubella, 98.3%; mumps, 92.2%; and varicella, 98%. No association was found between the susceptibility to at least 1 of MMRV virus infections and gender, age, duration of work, profession, and department of work in analysis either among the whole study group, or each hospital. The positive predictive value for the history of varicella was 100%, whereas it was 92% for MMR. The cost of vaccination for varicella was significantly expensive without screening before vaccination. However, there was not much difference for MMR infections.
CONCLUSION: A policy based on obtaining the history of varicella infection from the staff and then screening the ones with negative history and vaccination of only seronegative HCWs was found to be appropriate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097453     DOI: 10.1016/j.ajic.2006.04.213

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  19 in total

1.  High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.

Authors:  Maja Socan; Natasa Berginc
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

2.  Are healthcare workers immune to rubella?

Authors:  Eva Borràs; Magda Campins; María Esteve; Luis Urbiztondo; Sonia Broner; José María Bayas; Josep Costa; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-12-19       Impact factor: 3.452

3.  Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011.

Authors:  Cristina Taddei; Vega Ceccherini; Giuditta Niccolai; Barbara Rita Porchia; Sara Boccalini; Miriam Levi; Emilia Tiscione; Maria Grazia Santini; Simonetta Baretti; Paolo Bonanni; Angela Bechini
Journal:  Hum Vaccin Immunother       Date:  2014-10-30       Impact factor: 3.452

4.  Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV.

Authors:  Silvio Tafuri; Domenico Martinelli; Rosa Prato; Cinzia Germinario
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

5.  Determinants of varicella breakthrough: results of a 2012 case control study.

Authors:  Silvio Tafuri; Rocco Guerra; Maria Giovanna Cappelli; Domenico Martinelli; Rosa Prato; Cinzia Germinario
Journal:  Hum Vaccin Immunother       Date:  2014-01-07       Impact factor: 3.452

6.  Cost-effectiveness of workplace vaccination against measles.

Authors:  Luca Coppeta; Luca Morucci; Antonio Pietroiusti; Andrea Magrini
Journal:  Hum Vaccin Immunother       Date:  2019-07-24       Impact factor: 3.452

Review 7.  A global perspective of vaccination of healthcare personnel against measles: systematic review.

Authors:  Amy Parker Fiebelkorn; Jane F Seward; Walter A Orenstein
Journal:  Vaccine       Date:  2013-11-24       Impact factor: 3.641

8.  Long-term immunogenicity after measles vaccine vs. wild infection: an Italian retrospective cohort study.

Authors:  Francesco Paolo Bianchi; Simona Mascipinto; Pasquale Stefanizzi; Sara De Nitto; Cinzia Germinario; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2021-01-27       Impact factor: 3.452

Review 9.  Health economics of rubella: a systematic review to assess the value of rubella vaccination.

Authors:  Joseph B Babigumira; Ian Morgan; Ann Levin
Journal:  BMC Public Health       Date:  2013-04-29       Impact factor: 3.295

10.  Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.

Authors:  S Kumakura; H Shibata; K Onoda; N Nishimura; C Matsuda; M Hirose
Journal:  Epidemiol Infect       Date:  2013-04-11       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.